Overview

Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19

Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
Low radiation doses produce anti-inflammatory effects, which may be useful in the treatment of respiratory complications of COVID-19. This type of treatment is non-invasive and therefore, a priori, it can be used in all types of patients. Main objective: To evaluate the efficacy of low-dose lung irradiation as an adjunctive treatment in interstitial pneumonia in patients with COVID-19 by improving the PAFI O2 by 20% measured 48h after treatment with respect to the pre baseline measurement. -irradiation.
Phase:
N/A
Details
Lead Sponsor:
Grupo de Investigación Clínica en Oncología Radioterapia
Collaborators:
Hospital del Mar
Hospital Universitari Sant Joan de Reus
Hospital Universitario Madrid Sanchinarro
Treatments:
Azithromycin
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
Hydroxychloroquine
Lopinavir
Ritonavir
Tinzaparin